Vertebroplasty And Kyphoplasty market size is expected to reach $1.35 billion by 2030 at 5.3%, driven by rising incidence of sports-related spinal injuries.
Read MoreGlobal Ventral Hernia Treatment market size is expected to reach $7.3 billion by 2030 at 6.9%, impact of rising obesity rates on the growth of the ventral hernia treatment market
Read MoreVenous ulcer treatment market to reach $4.69 billion by 2030 at 7.1% cagr, driven by rising incidence of chronic diseases.
Read MoreGlobal Venous Thromboembolism market size is expected to reach $3.2 billion by 2030 at 5%, segmented as by deep vein thrombosis (dvt), proximal dvt, distal dvt, asymptomatic dvt
Read MoreVenous Leg Ulcer Treatment market size is expected to reach $6 Billion by 2030 at 6.9%, expansion of healthcare facilities driving the growth of the market due to advancements in medical technology
Read MoreVasovagal Syncope Treatment market size is expected to reach $2.24 billion by 2030 at 5.9%, driven by rising prevalence of cardiovascular disorders.
Read MoreGlobal Vasopressor market size is expected to reach $5.12 billion by 2030 at 6.6%, the rise in heart diseases propelling the growth of the market due to increasing cardiovascular complications
Read MoreGlobal Vasomotor Menopausal Symptoms (VMS) Treatment market size is expected to reach $26.48 billion by 2030 at 7.1%, segmented as by antidepressants, ssris (selective serotonin reuptake inhibitors)
Read MoreVasoactive Intestinal Peptide Tumor market size is expected to reach $2.15 billion by 2030 at 6%, driven by rising adoption of targeted therapies.
Read MoreVascular tissue matrix market to reach $1.89 billion by 2030 at 7.7% cagr, driven by rising adoption of minimally invasive procedures.
Read More